127 related articles for article (PubMed ID: 23118130)
1. CTLA4-IgG ameliorates homocysteine-accelerated atherosclerosis by inhibiting T-cell overactivation in apoE(-/-) mice.
Ma K; Lv S; Liu B; Liu Z; Luo Y; Kong W; Xu Q; Feng J; Wang X
Cardiovasc Res; 2013 Feb; 97(2):349-59. PubMed ID: 23118130
[TBL] [Abstract][Full Text] [Related]
2. Regulatory T cells ameliorate hyperhomocysteinaemia-accelerated atherosclerosis in apoE-/- mice.
Feng J; Zhang Z; Kong W; Liu B; Xu Q; Wang X
Cardiovasc Res; 2009 Oct; 84(1):155-63. PubMed ID: 19502284
[TBL] [Abstract][Full Text] [Related]
3. T-cell co-stimulation by CD28-CD80/86 and its negative regulator CTLA-4 strongly influence accelerated atherosclerosis development.
Ewing MM; Karper JC; Abdul S; de Jong RC; Peters HA; de Vries MR; Redeker A; Kuiper J; Toes RE; Arens R; Jukema JW; Quax PH
Int J Cardiol; 2013 Oct; 168(3):1965-74. PubMed ID: 23351788
[TBL] [Abstract][Full Text] [Related]
4. Blockade of T cell costimulation by CTLA4-Ig inhibits lung inflammation in murine hypersensitivity pneumonitis.
Israël-Assayag E; Fournier M; Cormier Y
J Immunol; 1999 Dec; 163(12):6794-9. PubMed ID: 10586079
[TBL] [Abstract][Full Text] [Related]
5. Regulation of surface and intracellular expression of CTLA4 on mouse T cells.
Alegre ML; Noel PJ; Eisfelder BJ; Chuang E; Clark MR; Reiner SL; Thompson CB
J Immunol; 1996 Dec; 157(11):4762-70. PubMed ID: 8943377
[TBL] [Abstract][Full Text] [Related]
6. The inhibitor of costimulation of T cells: abatacept.
Iannone F; Lapadula G
J Rheumatol Suppl; 2012 Jul; 89():100-2. PubMed ID: 22751606
[TBL] [Abstract][Full Text] [Related]
7. Role of redox factor-1 in hyperhomocysteinemia-accelerated atherosclerosis.
Dai J; Li W; Chang L; Zhang Z; Tang C; Wang N; Zhu Y; Wang X
Free Radic Biol Med; 2006 Nov; 41(10):1566-77. PubMed ID: 17045925
[TBL] [Abstract][Full Text] [Related]
8. CD28 and CTLA4 coordinately regulate airway inflammatory cell recruitment and T-helper cell differentiation after inhaled allergen.
Burr JS; Kimzey SL; Randolph DR; Green JM
Am J Respir Cell Mol Biol; 2001 May; 24(5):563-8. PubMed ID: 11350825
[TBL] [Abstract][Full Text] [Related]
9. PKM2-dependent metabolic reprogramming in CD4
Lü S; Deng J; Liu H; Liu B; Yang J; Miao Y; Li J; Wang N; Jiang C; Xu Q; Wang X; Feng J
J Mol Med (Berl); 2018 Jun; 96(6):585-600. PubMed ID: 29732501
[TBL] [Abstract][Full Text] [Related]
10. Role of CD80, CD86, and CTLA4 on mouse CD4(+) T lymphocytes in enhancing cell-cycle progression and survival after activation with PMA and ionomycin.
Mukherjee S; Maiti PK; Nandi D
J Leukoc Biol; 2002 Nov; 72(5):921-31. PubMed ID: 12429713
[TBL] [Abstract][Full Text] [Related]
11. CD28/CTLA4-B7 interaction is dispensable for T cell stimulation by mouse mammary tumor virus superantigen but not for B cell differentiation and virus dissemination.
Champagne E; Scarpellino L; Lane P; Acha-Orbea H
Eur J Immunol; 1996 Jul; 26(7):1595-602. PubMed ID: 8766566
[TBL] [Abstract][Full Text] [Related]
12. Nucleic acid vaccine-induced immune responses require CD28 costimulation and are regulated by CTLA4.
Horspool JH; Perrin PJ; Woodcock JB; Cox JH; King CL; June CH; Harlan DM; St Louis DC; Lee KP
J Immunol; 1998 Mar; 160(6):2706-14. PubMed ID: 9510170
[TBL] [Abstract][Full Text] [Related]
13. B7.2 expressed by T cells does not induce CD28-mediated costimulatory activity but retains CTLA4 binding: implications for induction of antitumor immunity to T cell tumors.
Greenfield EA; Howard E; Paradis T; Nguyen K; Benazzo F; McLean P; Höllsberg P; Davis G; Hafler DA; Sharpe AH; Freeman GJ; Kuchroo VK
J Immunol; 1997 Mar; 158(5):2025-34. PubMed ID: 9036945
[TBL] [Abstract][Full Text] [Related]
14. High concentrations of antigenic ligand activate and do not tolerize naive CD4 T cells in the absence of CD28/B7 costimulation.
Teh HS; Teh SJ
Cell Immunol; 1997 Jul; 179(1):74-83. PubMed ID: 9259774
[TBL] [Abstract][Full Text] [Related]
15. Evidence for the involvement of T cell costimulation through the B-7/CD28 pathway in atherosclerotic plaques from apolipoprotein E knockout mice.
Afek A; Harats D; Roth A; Keren G; George J
Exp Mol Pathol; 2004 Jun; 76(3):219-23. PubMed ID: 15126104
[TBL] [Abstract][Full Text] [Related]
16. Shikonin attenuates hyperhomocysteinemia-induced CD4
Lü SL; Dang GH; Deng JC; Liu HY; Liu B; Yang J; Ma XL; Miao YT; Jiang CT; Xu QB; Wang X; Feng J
Acta Pharmacol Sin; 2020 Jan; 41(1):47-55. PubMed ID: 31607752
[TBL] [Abstract][Full Text] [Related]
17. GSNOR modulates hyperhomocysteinemia-induced T cell activation and atherosclerosis by switching Akt S-nitrosylation to phosphorylation.
Li J; Zhang Y; Zhang Y; Lü S; Miao Y; Yang J; Huang S; Ma X; Han L; Deng J; Fan F; Liu B; Huo Y; Xu Q; Chen C; Wang X; Feng J
Redox Biol; 2018 Jul; 17():386-399. PubMed ID: 29860106
[TBL] [Abstract][Full Text] [Related]
18. Lymphoproliferative disorder in CTLA-4 knockout mice is characterized by CD28-regulated activation of Th2 responses.
Khattri R; Auger JA; Griffin MD; Sharpe AH; Bluestone JA
J Immunol; 1999 May; 162(10):5784-91. PubMed ID: 10229811
[TBL] [Abstract][Full Text] [Related]
19. The role of the CD28/B7 interaction in the regulation of NK cell responses during infection with Toxoplasma gondii.
Hunter CA; Ellis-Neyer L; Gabriel KE; Kennedy MK; Grabstein KH; Linsley PS; Remington JS
J Immunol; 1997 Mar; 158(5):2285-93. PubMed ID: 9036976
[TBL] [Abstract][Full Text] [Related]
20. Murine CTLA4-IgG treatment inhibits airway eosinophilia and hyperresponsiveness and attenuates IgE upregulation in a murine model of allergic asthma.
Van Oosterhout AJ; Hofstra CL; Shields R; Chan B; Van Ark I; Jardieu PM; Nijkamp FP
Am J Respir Cell Mol Biol; 1997 Sep; 17(3):386-92. PubMed ID: 9308926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
